Neurodegenerative diseases constitute a substantial financial, medial and social burden to populations around the world. With an aging population, this is set to increase.
As a result, neurodegenerative disease is a major focus in drug discovery and research. with Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) being three of the major study areas
iPSC technology enables a scalable source of cells derived from both healthy / control and patient / disease state donors for research and drug discovery.